I certainly don't see anywhere near that level of demand on an ongoing basis, particularly after COVID vaccines hit the scene and we develop some herd immunity. Only 3+M cases reported worldwide now, and you're projecting 100M a month?

If you want to get to $171/share, let's get licensed to treat 22 solid tumors